RecruitingNot ApplicableNCT06376604

Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies

Use of a Fasting Mimicking Diet in Patients Undergoing Chemotherapy for Gynecologic Malignancies


Sponsor

L-Nutra Inc

Enrollment

30 participants

Start Date

Sep 8, 2021

Study Type

INTERVENTIONAL

Summary

This study evaluates how lifestyle modifications that may be made to manage chemotherapy side effects in patients with gynecologic malignancies.


Eligibility

Sex: FEMALEMin Age: 35 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is examining whether following a special short-term fasting diet (called a fasting-mimicking diet) around chemotherapy sessions improves treatment outcomes or reduces side effects in women with gynecological cancers (like ovarian, uterine, or cervical cancer). **You may be eligible if...** - You are a woman between 35 and 70 years old - You have been diagnosed with a gynecological cancer confirmed by biopsy - You are scheduled for or currently receiving chemotherapy, with at least 6 cycles remaining - Your BMI is 18.5 or above and your kidneys are functioning well - You are willing to follow a 5-day fasting-mimicking diet **You may NOT be eligible if...** - You are pregnant or breastfeeding - You are a prisoner - You have diabetes or a history of low blood sugar (hypoglycemia) - You take daily medications that must be taken with food - You have a history of eating disorders, dementia, or serious heart, kidney, or psychiatric conditions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFasting Mimicking Diet

Subject will consume 6 cycles of 5-day fasting mimicking diet: 3 days prior to, the day of, and 1 day following chemotherapy treatments.

DRUGChemotherapy

6 cycles of standard chemotherapy for the gynecologic malignancy.


Locations(1)

The University of Tennessee Medical Center

Knoxville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06376604